2002Chinese Journal of Clinkal Oncology and RehabilitationRequires access

Clinical observation on radiotherapy plus chemotherapy in advanced nasopharyngeal carcinoma

Xiang Qi-chang

Open publisher page 0 citations

Abstract

ObjectiveTo evaluate the value of chemotherapy with radiotherapy in advanced nasopharyngeal carcinoma.Methods52 patients were divided randomly into two groups.Radiotherapy group(26 cases) was only treated with DT70~74Gy/7~7.5W in nasopharyngeal and DT50~65Gy/5~6.5W in the neck.Chemoradiotherapy group(26 cases) received chemotherapy with DDP+5FU during the first week and the fifth week.ResultsThe 1-,2- and 3-year survival rates were 88.46%?73.08%?53.85% in radiotherapy group and 92.31%?80.77%?73.08% in chemoradiotherapy group respectively.No significant difference was found between the two groups in 1- and 2-year survival rates,but there was in 3-year survival rate.ConclusionRadiotherapy with chemotherapy can increase the survival rates and decrease the distant metastasis in advanced nasopharyngeal carcinoma.

About this research paper

What this paper is about

ObjectiveTo evaluate the value of chemotherapy with radiotherapy in advanced nasopharyngeal carcinoma.Methods52 patients were divided randomly into two groups.Radiotherapy group(26 cases) was only treated with DT70~74Gy/7~7.5W in nasopharyngeal and DT50~65Gy/5~6.5W in the neck.Chemoradiotherapy group(26 cases) received chemotherapy with DDP+5FU during the first week and the fifth week.ResultsThe 1-,2- and 3-year survival rates were 88.46%?73.08%?53.85% in radiotherapy group and 92.31%?80.77%?73.08% in chemoradiotherapy group respectively.No significant difference was found between the two groups in 1- and 2-year survival rates,but there was in 3-year survival rate.ConclusionRadiotherapy with chemotherapy can increase the survival rates and decrease the distant metastasis in advanced nasopharyngeal carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ObjectiveTo evaluate the value of chemotherapy with radiotherapy in advanced nasopharyngeal carcinoma.Methods52 patients were divided randomly into two groups.Radiotherapy group(26 cases) was only treated with DT70~74Gy/7~7.5W in nasopharyngeal and DT50~65Gy/5~6.5W in the neck.Chemoradiotherapy group(26 cases) received chemotherapy with DDP+5FU during the first week and the fifth week.ResultsThe 1-,2- and 3-year survival rates were 88.46%?73.08%?53.85% in radiotherapy group and 92.31%?80.77%?73.08% in chemoradiotherapy group respectively.No significant difference was found between the two groups in 1- and 2-year survival rates,but there was in 3-year survival rate.ConclusionRadiotherapy with chemotherapy can increase the survival rates and decrease the distant metastasis in advanced nasopharyngeal carcinoma.

Key concepts: Nasopharyngeal carcinoma, Medicine, Radiation therapy, Chemotherapy, Chemoradiotherapy, Survival rate, Internal medicine, Distant metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on radiotherapy plus chemotherapy in advanced nasopharyngeal carcinoma — Research Paper | ScholarLens